ZVRA
NASDAQ · Pharmaceuticals
Zevra Therapeutics Inc
$11.32
+0.32 (+2.91%)
Open$11.14
Previous Close$11.00
Day High$11.60
Day Low$11.10
52W High$13.16
52W Low$7.16
Volume—
Avg Volume1.19M
Market Cap668.16M
P/E Ratio8.03
EPS$1.47
SectorPharmaceuticals
Analyst Ratings
Strong Buy
15 analysts
Price Target
-52.8% upside
Current
$11.32
$11.32
Target
$5.34
$5.34
$3.67
$5.34 avg
$6.76
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 109.74M | 30.86M | 109.96M |
| Net Income | 85.79M | -124,101,933 | 24.47M |
| Profit Margin | 78.2% | -424.5% | 22.3% |
| EBITDA | 94.43M | -97,531,026 | 54.29M |
| Free Cash Flow | — | — | 22.49M |
| Rev Growth | +116.7% | -6.2% | -4.5% |
| Debt/Equity | 0.40 | 1.50 | 0.54 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $948.45 | -2.72% | 36.1 | 913.24B |
| JNJ | Johnson & Johnson | $221.32 | -0.53% | 26.1 | 548.94B |
| MRK | Merck & Co. Inc. | $111.38 | -0.82% | 31.3 | 279.42B |
| PFE | Pfizer Inc. | $25.68 | -3.02% | 19.3 | 150.09B |
| BMY | Bristol-Myers Squibb Co | $56.16 | -0.16% | 17.0 | 120.08B |
| ZTS | Zoetis Inc | $82.83 | -5.13% | 21.5 | 57.37B |